RxDoctor Payments Data

Hosam El Sayed, MD

Vascular Surgery · Virginia Beach, VANPI 1063598977

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (36.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 65.4% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $18,633 and has fallen 76.1% since, to $4,461 in 2025. Among vascular surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,783in general payments, 2019–2025

Across 328 payments — averaging $182.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$39K
  • W. L. Gore & Associates, Inc.$5K
  • Covidien LP$5K
  • Cook Medical LLC$2K
  • Penumbra, Inc.$2K
  • Bolton Medical Inc$2K
  • plus $6K from 19 others
$17,197in research payments, 2019–2025

Across 8 payments — averaging $2149.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$17K

What the payments were for

  • Consulting fees$17,43829%
  • Speaking & faculty fees$4,8808%
  • Grants$1,2892%
  • Travel & lodging$14,46724%
  • Food & beverage$21,71036%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,783 in reported general payments places this provider in the 90th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$305,562
Medicare patients
3,460
Services billed
4,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol36$297
ClopidogrelClopidogrel Bisulfate11$56

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Virginia Beach

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →